BCL2 and autoimmune thrombocytopenic purpura: To further investigate the underling mechanisms involved in these changes, we analyzed the expression of Bcl2, a key protein in the intrinsic pathway of apoptosis [28], in ITP-MSCs treated with JWH-133 and Dexa.